New Report Shows Cancer Survival Rates are Improving

According to a recent report from the American Cancer Society, individuals diagnosed with cancer are notably living longer than in previous decades.

This report, marking the 75th Annual Cancer Statistics Report, emphasizes that advancements in cancer research have led to more effective treatments. Essentially, cancer is increasingly seen as a manageable chronic disease rather than a guaranteed death sentence.

Back in the mid-1970s, the five-year survival rate for cancer in the United States was around 50%. Today, it has improved to approximately 70%.

The report attributes these positive changes to better treatments and earlier diagnoses, noting that screening for cancers like breast and prostate plays a significant role in enhancing survival rates.

As the report highlights, “For example, the introduction of tyrosine kinase inhibitors has significantly improved survival rates in certain leukemia types, allowing many patients to lead nearly normal lives.”

Notably, the survival rates for some cancers have experienced substantial increases: liver cancer rates increased from 7% in the 1990s to 22% in 2023, lung cancer rates rose from 15% to 28%, and myeloma survival rates jumped from 32% to 62%.

The ACS further explains that survival rates have shown improvement for both local-stage cancers—where tumors have started to spread to nearby organs—and distant-stage cancers, which have spread further away. The relative survival rate for distant cancers has more than doubled, soaring from 17% in the mid-1990s to 35% for those diagnosed between 2015 and 2021.

Dr. Calvin Chao of Alterra of California highlights that while numbers are encouraging, they don’t tell the whole story. Many elements contribute to these advancements, but he underscores that personalized treatment approaches utilizing predictive insights are crucial in guiding care.

He states that these insights allow clinicians to identify the most beneficial treatments for each patient and to avoid unnecessary side effects from treatments that don’t offer additional advantages.

Dr. Yvonne Estrin, a breast radiologist, echoes this sentiment, indicating that early detection and improved testing protocols have had a significant impact on treatment success. Screening mammograms, for instance, can now start at age 40, leading to earlier detection of breast cancer and ultimately reducing morbidity and mortality rates.

Increasing Cancer Cases Amid Declining Mortality Rates

Despite the encouraging trends in survival rates, the ACS estimates that approximately 2.1 million new cancer cases are expected in 2026, averaging about 5,800 diagnoses each day. Breast cancer remains the most commonly diagnosed cancer among women, more than twice as prevalent as lung cancer. Other increasing cancers for women include liver, melanoma, and uterine cancers.

For men, prostate cancer cases continue to rise. It is diagnosed twice as often as lung cancer, which is the second most common. The report also points out that oral and pancreatic cancers are increasing in both genders.

Even with these grim statistics, it’s worth noting that cancer remains the leading cause of death for American men aged 60-79 and for women aged 40-79. In general, it is the second leading cause of death in the U.S., following heart disease.

The ACS projects that around 626,140 cancer deaths will occur in the U.S. in 2026, which translates to roughly 1,720 deaths daily. The most common causes are lung, colorectal, and pancreatic cancers.

Nonetheless, overall mortality rates have been on a decline. Since peaking in 1991, cancer death rates have decreased by about 34%. The ACS estimates that around 4.8 million cancer deaths were avoided by 2023. Particularly, deaths from lung cancer have decreased significantly, by 62% for men since 1990 and by 38% for women since 2002.

Among men, prostate cancer death rates have seen a 53% drop since 1993; colorectal cancer rates have decreased by 55% between 1980 and 2023. For women, breast cancer mortality has declined by 44% since 1989.